AdipoSeeds Overview

  • Year Founded
  • 2016

Year Founded

  • Status
  • Private

  • Employees
  • 11

Employees

  • Latest Deal Type
  • Later Stage VC

  • Investors
  • 15

AdipoSeeds General Information

Description

Developer of an allogeneic platelet product derived from human adipose tissue, designed to address platelet shortages and provide an alternative source of platelets for medical treatments. The company offers a technology to produce platelets from mesenchymal stem cells without complex and costly gene transfer, enabling biotechnology companies to use adipose-derived platelets in blood products and wound care medicines.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 35 Shinanomachi
  • Keio University, School of Medicine, Research Park 9N2, Shibuya-ku
  • Tokyo, 160-8582
  • Japan
+81
Primary Industry
Biotechnology
Other Industries
Drug Delivery
Vertical(s)
Corporate Office
  • 35 Shinanomachi
  • Keio University, School of Medicine, Research Park 9N2, Shibuya-ku
  • Tokyo, 160-8582
  • Japan
+81

AdipoSeeds Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

AdipoSeeds Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Later Stage VC 16-Oct-2026 Completed Pre-Clinical Trials
5. Later Stage VC 12-Dec-2022 Completed Pre-Clinical Trials
4. Early Stage VC 16-Oct-2020 Completed Pre-Clinical Trials
3. Seed Round 01-Nov-2019 Completed Startup
2. Early Stage VC 20-Dec-2017 Completed Startup
1. University Spin-Out 07-Jul-2016 Completed Startup
To view AdipoSeeds’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

AdipoSeeds Patents

AdipoSeeds Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026150938-A1 Prevention or treatment of graft versus host disease using platelets produced from adipose tissue-derived mesenchymal stem cells Pending 10-Jan-2025
WO-2026018855-A1 Method for evaluating platelet function Pending 18-Jul-2024
EP-4792820-A1 Method for producing platelet-rich plasma Pending 12-Oct-2023
WO-2025079609-A1 Method for producing platelet-rich plasma Inactive 12-Oct-2023
EP-4527394-A1 Novel method for preserving platelets Pending 16-May-2022 C12N5/526
To view AdipoSeeds’s complete patent history, request access »

AdipoSeeds Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

AdipoSeeds Investors (15)

Investor Name Investor Type Holding Investor Since Participating Rounds
Kohjin Bio Corporation Minority
Sysmex (Diagnostic Equipment) Corporation Minority
Toho Holdings Holding Company Minority
DCI Partners Venture Capital Minority
Gemseki Corporate Venture Capital Minority
You’re viewing 5 of 15 investors. Get the full list »

AdipoSeeds FAQs

  • When was AdipoSeeds founded?

    AdipoSeeds was founded in 2016.

  • Where is AdipoSeeds headquartered?

    AdipoSeeds is headquartered in Tokyo, Japan.

  • What is the size of AdipoSeeds?

    AdipoSeeds has 11 total employees.

  • What industry is AdipoSeeds in?

    AdipoSeeds’s primary industry is Biotechnology.

  • Is AdipoSeeds a private or public company?

    AdipoSeeds is a Private company.

  • What is AdipoSeeds’s current revenue?

    The current revenue for AdipoSeeds is .

  • How much funding has AdipoSeeds raised over time?

    AdipoSeeds has raised $11.6M.

  • Who are AdipoSeeds’s investors?

    Kohjin Bio, Sysmex (Diagnostic Equipment), Toho Holdings, DCI Partners, and Gemseki are 5 of 15 investors who have invested in AdipoSeeds.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process